China Immunotech

Genhe, Inner Mongolia, China

Company profile

China Immunotech company profile

China Immunotech is a small molecule innovative drug R&D company developing immune cell therapy technologies and products. Including CAR-T and TCR-T cell therapy with independent intellectual property rights. It was founded in March 2018 by famous immunologists.

Business identity

Website: http://www.cn-immunotech.com
Contact email: [email protected]
Operating status: Active
Company type: For Profit
Employee range: 00101-00250 employees
Revenue range: $10K+
Founded: 2018-03-01

Headquarters

Headquarters: Genhe, Inner Mongolia, China
Country code: CN
Continent: Asia

Capital profile

Funding and company signals

Funding stage: Early Stage Venture
Funding rounds: 2
Total equity funding: $31M
Last funding: Series B / 2022-07-18
Last equity funding: Series B
Investors: 4
Lead investors: 1
Articles: 1

Categories and groups

Biopharma Biotechnology Health Care Medical Pharmaceutical Biotechnology Health Care Science and Engineering

Founders and investors

Lead investors

Tsinghua Holdings Capital

Investors

Hankang CapitalLotus Lake VenturesTsinghua Holdings CapitalVertex Ventures China

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.